Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?. Issue 12 (2nd December 2019)

Record Type:: Journal Article
Title:: Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?. Issue 12 (2nd December 2019)
Main Title:: Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?
Authors:: Dalgleish, Angus G
Abstract:
Is Part Of:: Expert review of anticancer therapy. Volume 19:Issue 12(2019)
Journal:: Expert review of anticancer therapy
Issue:: Volume 19:Issue 12(2019)
Issue Display:: Volume 19, Issue 12 (2019)
Year:: 2019
Volume:: 19
Issue:: 12
Issue Sort Value:: 2019-0019-0012-0000
Page Start:: 1001
Page End:: 1003
Publication Date:: 2019-12-02
Subjects:: Immunotherapy -- oncology -- cancer vaccines -- checkpoint inhibitors -- biomarkers
Cancer -- Treatment -- Periodicals
616.99406
Journal URLs:: http://informahealthcare.com ↗
http://www.future-drugs.com/loi/era ↗
DOI:: 10.1080/14737140.2019.1696676 ↗
Languages:: English
ISSNs:: 1473-7140
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002982
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 12503.xml